Overview

• Madhya Pradesh flagged two additional products—ReLife and Respifresh TR—with diethylene glycol above limits (0.616% and 1.342%) and ordered seizures and a halt to sales.
• Government labs in Tamil Nadu and Madhya Pradesh found exceptionally high diethylene glycol in Coldrif batch SR-13 (~46–48.6% w/v), prompting prohibitions in multiple states including Punjab and Uttar Pradesh.
• The petition by advocate Vishal Tiwari seeks a court‑monitored commission led by a retired Supreme Court judge, transfer of all FIRs to the CBI, compensation for families, and mandatory pre‑distribution testing with national recalls.
• Enforcement expanded with an FIR against manufacturer Sresan Pharmaceuticals, the arrest of a prescribing paediatrician in Chhindwara, an SIT inquiry, and suspensions or transfers of drug regulators in Madhya Pradesh.
• Health authorities issued advisories and inspections nationwide, including DCGI guidance limiting cough‑syrup use in very young children and state drives to trace and seize stocks, as reported deaths have reached at least 14.